Bio-Bridge gains Japan patent
OAK BROOK - Bio-Bridge Science Inc., a biotechnology company engaged in the commercial development of vaccines and vaccine-related products announced Monday that the Japanese Patent Office has issued a patent regarding the use of the papilloma pseudovirus. Bio-Bridge Science has previously been granted patents relating to the technology in the United States and China.
Article Comments
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked.
If a comment violates these standards or our terms of service, click the "flag" link in the lower-right corner of the comment box. To find our more, read our FAQ.